Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.0%

6 terminated/withdrawn out of 150 trials

Success Rate

92.1%

+5.6% vs industry average

Late-Stage Pipeline

24%

36 trials in Phase 3/4

Results Transparency

7%

5 of 70 completed trials have results

Key Signals

30 recruiting5 with results

Enrollment Performance

Analytics

N/A
40(38.1%)
Phase 2
26(24.8%)
Phase 3
19(18.1%)
Phase 4
17(16.2%)
Phase 1
3(2.9%)
105Total
N/A(40)
Phase 2(26)
Phase 3(19)
Phase 4(17)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (150)

Showing 20 of 150 trials
NCT06227754Not ApplicableRecruiting

OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts

Role: lead

NCT07562932Not ApplicableNot Yet Recruiting

Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock

Role: lead

NCT04968808Not ApplicableRecruiting

Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)

Role: lead

NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

Role: collaborator

NCT06088121Not ApplicableRecruiting

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Role: collaborator

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT07002164Not ApplicableRecruiting

Timing of Coronary Angiography in NSTEMI Complicated by Acute HF

Role: lead

NCT07482228Recruiting

Long-term Clinical Outcomes After Retinal Artery Occlusion

Role: lead

NCT05124249Recruiting

Imaging and Physiologic Evaluation of Coronary Artery Disease

Role: lead

NCT05369182Active Not Recruiting

Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)

Role: collaborator

NCT05221931Not ApplicableActive Not Recruiting

Drug-Coated Balloon in Patients With High Bleeding Risk

Role: collaborator

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT07390461Not ApplicableNot Yet Recruiting

Effectiveness of Artificial Intelligence Integrated Mixed Reality-based High-Alert Medications Management Simulation Program

Role: lead

NCT04769362Phase 4Recruiting

Long-term Beta-blocker Therapy After Acute Myocardial Infarction

Role: collaborator

NCT06742931Not ApplicableRecruiting

Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2

Role: collaborator

NCT07241143Not ApplicableNot Yet Recruiting

Extra-Peritoneal Tunneling Versus Conventional Drain Fixation After Anterior or Low Anterior Resection

Role: collaborator

NCT06868186Not ApplicableRecruiting

A Multicenter Study of RUS NE

Role: collaborator

NCT06954714Not ApplicableRecruiting

Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions

Role: lead

NCT06124833Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Role: collaborator

NCT04010955Active Not Recruiting

Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)

Role: collaborator